Novel Diagnostics

“You can plan research … you cannot plan discovery.”

Lord Ernest Rutherford

Development of Novel Diagnostics

Antimicrobial Resistance (AMR) is a growing threat this is already costing the global economy billions of pounds per year, notwithstanding the personal and clinical impacts it has on patients and their families. A seminal report by Professor Jim O’Neill stated explicitly that one of the few methods to combat this threat is with the application of rapid, sensitive diagnostics that can determine bacterial susceptibility in a few minutes. Our research is focused upon this task and has met with great success. In 2016 we won a Longitude Discovery Award. In 2017 we were runner up for the Times Higher Education Awards and in 2018 we both won the Scottish Life Sciences Award for New Innovation and spun out a company to commercialise our technology.

We are in the process of developing new technology and welcome interest from potential new students and colleagues.